Black Diamond Therapeutics, Inc. (BDTX)
3.00
+0.42
(+16.28%)
USD |
NASDAQ |
May 19, 16:00
2.94
-0.06
(-2.00%)
After-Hours: 20:00
Black Diamond Therapeutics Shareholders Equity (Quarterly) : 104.30M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Editas Medicine, Inc. | 4.408M |
| IDEAYA Biosciences, Inc. | 937.27M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 132.92M |
| Total Liabilities (Quarterly) | 28.62M |
| Debt to Equity Ratio | 0.1714 |
| Current Ratio | 8.461 |
| Net Debt Paydown Yield | 0.71% |